Injective vs Osmosis — how do they compare? Injective trades at Rp92,698 (market cap Rp9,18T, Rp1,72T 24h volume), while Osmosis trades at Rp610.82 (market cap Rp475,62M, Rp47,42M 24h volume). The key difference: Injective is far larger — about 19301.1× Osmosis's market cap, and Osmosis's supply is capped (781M / 1B OSMO (79%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Osmosis for 21 Days on average.
| INJ | OSMO | |
|---|---|---|
Market Cap | Rp9,18T | Rp475,62M |
Volume (24h) | Rp1,72T | Rp47,42M |
Circulating Supply | 100M INJ | 781M / 1B OSMO (79%) |
Typical Hold Time | 36 Days | 21 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Osmosis (OSMO) is trading at Rp614.1 with a market cap of Rp479.2M, showing a bearish technical signal from moving averages and oscillators. The current price is near the pivot point of Rp607, with support at Rp597 and resistance at Rp623. On-chain metrics indicate 79% of the max supply is circulating, with an average hold time of 21 days. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental developments quiet.
Overall outlook remains cautious due to bearish technicals and neutral sentiment, but the oversold RSI_6 at 21.00 may signal a short-term buying opportunity. Key risks include high volatility and regulatory uncertainty in crypto markets. Investors should monitor exchange liquidity and whale movements for signs of trend reversal.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Osmosis, launched in 2021, is a blockchain designed for DeFi applications and a decentralized exchange (DEX). The Osmosis DEX is the main platform on its network, acting as the top DEX and DeFi hub within the Cosmos ecosystem and beyond.
Read more on OSMO →